This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. A.
Right arrow Articles by Preston, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. A.
Right arrow Articles by Preston, B. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2008, p. 329-332, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.01004-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Types 1 and 2 Exhibit Comparable Sensitivities to Zidovudine and Other Nucleoside Analog Inhibitors In Vitro{triangledown}

Robert A. Smith,1* Geoffrey S. Gottlieb,2 Donovan J. Anderson,1 Crystal L. Pyrak,1 and Bradley D. Preston1

Departments of Pathology,1 Medicine, University of Washington, Seattle, Washington2

Received 31 July 2007/ Returned for modification 14 September 2007/ Accepted 23 October 2007

Using an indicator cell assay that directly quantifies viral replication, we show that human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2, respectively) exhibit similar sensitivities to 3'-azido-3'-deoxythymidine (zidovudine) as well as other nucleoside analog inhibitors of reverse transcriptase. These data support the use of nucleoside analogs for antiviral therapy of HIV-2 infection.

* Corresponding author. Mailing address: University of Washington, Department of Pathology, K-046 HSB, Box 357705, 1959 NE Pacific St., Seattle, WA 98195. Phone: (206) 221-5650. Fax: (206) 543-3967. E-mail: smithra{at}u.washington.edu

{triangledown} Published ahead of print on 29 October 2007.

Antimicrobial Agents and Chemotherapy, January 2008, p. 329-332, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.01004-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ntemgwa, M. L., Toni, T. d., Brenner, B. G., Camacho, R. J., Wainberg, M. A. (2009). Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2. Antimicrob. Agents Chemother. 53: 3611-3619 [Full Text]  
  • Ntemgwa, M. L., Toni, T. d., Brenner, B. G., Oliveira, M., Asahchop, E. L., Moisi, D., Wainberg, M. A. (2009). Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2. Antimicrob. Agents Chemother. 53: 708-715 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»